AADI Aadi Bioscience | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Burns Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.87 +5.1% | | Neutral | |
ACLX Arcellx | Initiated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.77 +0.1% | $85.00 | Outperform | |
AGYS Agilysys | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.21 -2.0% | $100.00 | Buy ➝ Buy | |
AGYS Agilysys | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.21 -2.0% | $95.00 ➝ $100.00 | Outperform ➝ Outperform | |
AIR AAR | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.79 -0.5% | $81.00 ➝ $86.00 | Buy ➝ Buy | |
AIRS AirSculpt Technologies | Downgraded by | SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.67 -1.5% | $8.25 ➝ $5.00 | Outperform ➝ Market Perform | |
|
ALLO Allogene Therapeutics | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.90 +5.1% | $4.40 ➝ $4.60 | Hold ➝ Hold | |
ALT Altimmune | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.37 +2.1% | $12.00 | Buy ➝ Buy | |
AMLX Amylyx Pharmaceuticals | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.82 +4.0% | $4.00 ➝ $3.00 | Neutral ➝ Neutral | |
ANNX Annexon | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.87 +2.5% | $30.00 | Buy ➝ Buy | |
APA APA | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.20 -0.6% | $35.00 ➝ $33.00 | Neutral ➝ Neutral | |
ARIS Aris Water Solutions | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.28 -3.3% | $16.00 ➝ $20.00 | Outperform ➝ Outperform | |
ASPN Aspen Aerogels | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.33 +1.2% | $29.00 ➝ $30.00 | Overweight ➝ Overweight | |
ATO Atmos Energy | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.33 -0.7% | $130.00 ➝ $132.00 | Equal Weight ➝ Overweight | |
AUGX Augmedix | Downgraded by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.34 +4.9% | $5.00 ➝ $1.50 | Outperform ➝ Inline | |
AUGX Augmedix | Downgraded by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.34 +4.9% | $5.00 | Buy ➝ Hold | |
AVTE Aerovate Therapeutics | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chico Subscribe to MarketBeat All Access for the recommendation accuracy rating | $19.14 -3.5% | $41.00 | Outperform ➝ Outperform | |
BBIO BridgeBio Pharma | Initiated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.50 -2.1% | $50.00 | Outperform | |
BJ BJ's Wholesale Club | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $78.48 +0.5% | $76.00 ➝ $78.00 | In-Line ➝ In-Line | |
BMRN BioMarin Pharmaceutical | Initiated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.50 -0.7% | $113.00 | Outperform | |
BNTX BioNTech | Initiated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.72 +1.1% | $100.00 | Inline | |
BPMC Blueprint Medicines | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $108.05 +1.3% | $140.00 | Overweight | |
BYON Beyond | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.79 +17.4% | $37.00 | Outperform ➝ Outperform | |
CALC CalciMedica | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.00 -10.7% | $20.00 | Buy ➝ Buy | |
CAPR Capricor Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.44 +2.6% | $40.00 | Buy ➝ Buy | |
CHRD Chord Energy | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $181.10 +0.9% | $230.00 ➝ $231.00 | Overweight ➝ Overweight | |
CHUY Chuy's | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.45 +1.2% | $36.00 ➝ $32.00 | Hold ➝ Hold | |
CMS CMS Energy | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.91 0.0% | $68.00 ➝ $71.00 | Outperform ➝ Outperform | |
COCP Cocrystal Pharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.75 +1.2% | $10.00 | Buy ➝ Buy | |
CRH CRH | Initiated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $82.12 -2.0% | $110.00 | Outperform | |
CRNX Crinetics Pharmaceuticals | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.93 -0.1% | $65.00 | Overweight ➝ Overweight | |
CTRA Coterra Energy | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.98 -0.4% | $37.00 ➝ $39.00 | Overweight ➝ Overweight | |
CX CEMEX | Initiated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.96
| $9.00 | Underperform | |
CYTK Cytokinetics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.89 -6.8% | $94.00 | Buy ➝ Buy | |
DCTH Delcath Systems | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.40 -5.4% | $25.00 | Overweight | |
DINO HF Sinclair | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.19 -0.8% | $70.00 ➝ $65.00 | Overweight ➝ Overweight | |
DNB Dun & Bradstreet | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.55 +0.9% | $17.00 | Buy ➝ Buy | |
DSGX The Descartes Systems Group | Initiated by | Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.41 +0.0% | $90.00 | Neutral | |
DVN Devon Energy | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.88 -0.5% | $60.00 ➝ $61.00 | Overweight ➝ Overweight | |
EHAB Enhabit | Upgraded by | SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.64 +3.6% | $8.50 | Underperform ➝ Market Perform | |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
ELEV Elevation Oncology | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.54 +7.9% | $8.00 | Overweight | |
EOG EOG Resources | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $129.40 -0.5% | $153.00 ➝ $154.00 | Overweight ➝ Overweight | |
EPAM EPAM Systems | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $190.72 +4.0% | $345.00 ➝ $258.00 | Buy ➝ Buy | |
EVBG Everbridge | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.71 -0.1% | $29.00 ➝ $35.00 | Neutral ➝ Neutral | |
EXPD Expeditors International of Washington | Upgraded by | BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.61 -0.6% | $112.00 | Underperform ➝ Neutral | |
FOLD Amicus Therapeutics | Upgraded by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.04 -2.1% | $13.00 | Neutral ➝ Buy | |
FTRE Fortrea | Upgraded by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.11 -14.9% | $45.00 ➝ $36.00 | Neutral ➝ Outperform | |
FULC Fulcrum Therapeutics | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.35 -1.6% | $16.00 ➝ $14.00 | Outperform ➝ Outperform | |
FULC Fulcrum Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.35 -1.6% | $17.00 | Buy ➝ Buy | |
GBIO Generation Bio | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.84 -5.0% | $5.00 | Outperform ➝ Outperform | |
HD Home Depot | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $340.99 -1.6% | $360.00 ➝ $360.00 | Market Perform ➝ Market Perform | |
IKNA Ikena Oncology | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.32 +2.3% | $8.00 | Outperform ➝ Outperform | |
IMNN Imunon | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.48 +7.2% | $13.00 ➝ $12.00 | Buy ➝ Buy | |
INO Inovio Pharmaceuticals | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.36 +6.7% | $20.00 | Overweight | |
INSM Insmed | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.83 -0.5% | $52.00 | Buy ➝ Buy | |
ITRM Iterum Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.52 -1.9% | $6.00 | Buy ➝ Buy | |
LPTX Leap Therapeutics | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.83 +1.8% | $7.00 ➝ $5.50 | Buy ➝ Buy | |
MANH Manhattan Associates | Initiated by | Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $213.62 -1.9% | $260.00 | Buy | |
MPW Medical Properties Trust | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57 +16.5% | $5.00 | Outperform ➝ Sector Perform | |
MRNA Moderna | Initiated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.67 +7.1% | $120.00 | In-Line | |
NBIX Neurocrine Biosciences | Initiated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.15 -0.4% | $175.00 | Outperform | |
NOG Northern Oil and Gas | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.61 -0.3% | $42.00 ➝ $43.00 | Neutral ➝ Neutral | |
NOTV Inotiv | Downgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17 +10.9% | $11.50 ➝ $3.75 | Buy ➝ Hold | |
NRIX Nurix Therapeutics | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.94 +3.2% | $20.00 | Overweight | |
NTRA Natera | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.33 -1.9% | $110.00 ➝ $120.00 | Overweight ➝ Overweight | |
OII Oceaneering International | Reiterated by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.30 +0.2% | $22.00 ➝ $21.00 | Equal Weight ➝ Underweight | |
ONCY Oncolytics Biotech | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.17
| $5.00 | Buy ➝ Buy | |
ORN Orion Group | Initiated by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.70 +1.9% | $14.00 | Buy | |
PLNT Planet Fitness | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.56 +0.9% | $68.00 ➝ $78.00 | Neutral ➝ Overweight | |
PMVP PMV Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.13 +4.4% | $5.00 | Buy ➝ Buy | |
PRAX Praxis Precision Medicines | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.19 -7.4% | $105.00 | Buy ➝ Buy | |
PSFE Paysafe | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.69 +3.4% | $14.00 ➝ $16.00 | Neutral ➝ Neutral | |
QBTS D-Wave Quantum | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.37 +5.4% | $2.50 | Buy ➝ Buy | |
RAPT RAPT Therapeutics | Reiterated by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.40 +1.6% | | Outperform ➝ Peer Perform | |
RBLX Roblox | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.97 -1.5% | $55.00 ➝ $35.00 | Buy ➝ Neutral | |
RCEL AVITA Medical | Target Lowered by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.35 +1.1% | $22.00 ➝ $21.00 | Overweight ➝ Overweight | |
REGN Regeneron Pharmaceuticals | Initiated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $976.96 +0.3% | $1,150.00 | Outperform | |
RPHM Reneo Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.59 -12.2% | $1.50 | Neutral ➝ Neutral | |
SAM Boston Beer | Upgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $283.90 -2.5% | $335.00 ➝ $360.00 | Hold ➝ Buy | |
SE SEA | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.46 -0.7% | $72.00 | Outperform ➝ Outperform | |
SHIM Shimmick | Downgraded by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.64
| $9.00 ➝ $3.50 | Buy ➝ Neutral | |
SNSE Sensei Biotherapeutics | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.57 +4.0% | $5.00 | Overweight | |
SPRB Spruce Biosciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.81 -3.6% | | Neutral | |
SPSC SPS Commerce | Initiated by | Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $192.60 +0.1% | $220.00 | Buy | |
SRPT Sarepta Therapeutics | Upgraded by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $131.70 -0.1% | $180.00 | Market Perform ➝ Outperform | |
STRO Sutro Biopharma | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.23 +1.9% | $8.00 | Outperform ➝ Outperform | |
STRO Sutro Biopharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.23 +1.9% | $12.00 | Buy ➝ Buy | |
STX Seagate Technology | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $93.15 -0.9% | $110.00 | Buy | |
TBPH Theravance Biopharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.58 +2.1% | $20.00 | Buy ➝ Buy | |
TCRX TScan Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.01 +3.6% | $15.00 | Buy ➝ Buy | |
Guard Against the Coming Financial Upheaval (Ad) America’s Most Shocking Financial Story…
Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. |
TENB Tenable | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.90 +0.3% | $62.00 | Buy ➝ Buy | |
TERN Terns Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.89 +5.9% | $5.50 | Neutral ➝ Neutral | |
TRNO Terreno Realty | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.92 -0.3% | $68.00 ➝ $60.00 | Neutral ➝ Neutral | |
TSHA Taysha Gene Therapies | Reiterated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.40 +2.6% | $2.00 ➝ $8.00 | Hold ➝ Buy | |
ULTA Ulta Beauty | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $403.96 +0.6% | $605.00 ➝ $476.00 | Neutral ➝ Neutral | |
ULTA Ulta Beauty | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $403.96 +0.6% | $565.00 ➝ $475.00 | Hold ➝ Hold | |
ULY Urgent.ly | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.15 -9.3% | $5.00 | Buy ➝ Buy | |
URGN UroGen Pharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.07 +2.6% | $54.00 | Buy ➝ Buy | |
URGN UroGen Pharma | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.07 +2.6% | $34.00 ➝ $32.00 | Outperform ➝ Outperform | |
VERU Veru | Initiated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.33
| $5.00 | Buy | |
VRCA Verrica Pharmaceuticals | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.56 +19.5% | $8.00 ➝ $16.00 | Buy ➝ Buy | |
VRCA Verrica Pharmaceuticals | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.56 +19.5% | $13.00 ➝ $14.00 | Buy ➝ Buy | |
VTEX VTEX | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.55 -1.1% | $9.00 ➝ $9.00 | Neutral ➝ Overweight | |
VYGR Voyager Therapeutics | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.48 +0.5% | $10.00 ➝ $8.00 | Neutral ➝ Neutral | |
WDC Western Digital | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $70.97 -0.9% | $90.00 | Buy | |
WFRD Weatherford International | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $122.75 +0.8% | $155.00 | Buy | |
XPRO Expro Group | Upgraded by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.18 +1.1% | $18.00 ➝ $27.00 | Equal Weight ➝ Overweight | |